Toxic megacolon is a rare complication of shigellosis (bacillary dysentery) but it occurs with acute infections caused by Salmonella spp, Campylobacter jejuni, and Yersinia enterocolitica.'4 A correct diagnosis is essential because treatment with corticosteroids can cause serious, potentially fatal complications. Furthermore, an unnecessary colonic resection may be performed inadvertently. The following two cases show that toxic megacolon can result from shigellosis in travellers even when faecal culture is negative.
Case reports CASE 1
A 43 year old man returned from a two week stay in Accra, Ghana, where he had been admitted to hospital with a five day history of severe diarrhoea of acute onset. Chloramphenicol and trimethoprim had been ineffective. On admission he was febrile, dehydrated, and had watery stools (>six daily In If the initial cultures are negative and colonic symptoms and signs are not typical of ulcerative colitis or Crohn's disease strenuous efforts should be made to reach a bacterial diagnosis, and steroids should be used only with caution. A laparotomy may suggest the correct diagnosis first and allow decompression rather than resection of the colon. Prickly heat is a lay term to describe a rash that produces an annoying pricking sensation. Miliaria is the medical term. The condition is due to the inability of sweat to escape from the skin either because the air is too humid or because the passage from the sweat duct to the skin is blocked or narrowed. It usually consists of small round macules, but these may coalesce to produce sheets of erythema. The flexures are the areas usually affected but so may be the face and trunk, especially in babies. The condition is precipitated by sweating, particularly in a humid atmosphere. So it is common in the humid tropics and in temperate climates when the weather is warm and humid, particularly when exercise provokes profuse sweating.
There is a condition affecting the feet known as juvenile plantar dermatosis. This is caused by occlusion of the ducts as a result of wearing shoes that do not permit the ready escape of sweat in conjunction with exercise, which causes a shearing stress on the skin rupturing the delicate sweat duct as it courses through the thick corneous layer of the sole.
Treatment consists of avoiding conditions that provoke sweating. Moving out of the hot sun, stopping exercise, and cooling the skin with cold water or ice may prove effective. The rash will subside within an hour or so. In the humid tropics this may prove impossible, so the sufferer should seek refuge in an air conditioned atmosphere where the humidity is low. If the condition becomes chronic the sufferer may have to leave the tropics because' chronic miliaria may permanently damage the sweat glands. Topical remedies, such as lanolin or moisturising creams, may soften the sweat duct orifices anQ give some relief, but the precipitating factors must be avoided. Children with the foot disorder need to wear shoes with leather uppers and leather linings, which allow the sweat to escape. -ALAN B SHRANK, consultant dermatologist, Shrewsbury A 40 year old woman has obtained complete relief from severe migraine attacks since starting propranolol 80 mg daily. Her mother suffered similar attacks continuing into old age. Should the patient be encouraged to continue propranolol indefinitely or is there a risk of long term complications?
No serious long term complications have been reported with propranolol, but it may aggravate asthma or heart failure. Although the risks of this treatment would seem to be minimal, the question whether it should be continued indefinitely is debatable. In common with other a blocking drugs propranolol does reduce drive. If it becomes necessary to increase the dose above 80 mg daily there may be circulatory effects such as severe bradycardia and hypotension. In general indefinite drug treatment for a condition that does not threaten life and is not associated with serious complications should bc_yoided. As a compromise it would seem reasonable to review th pos4tion after a year and if the patient has been free from attacks grad withdrawal should be considered.-BRYAN ASHWORTH, consultant neurologist, Edinburgh Diamond S, Kudrow L, Stevens J, Shapiro DB. Long-term study of propranolol in the treatment of migraine. Headache 1982;22:268-71.
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